158 related articles for article (PubMed ID: 8609807)
1. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited.
Berg PA; Klein R
Liver; 1995 Dec; 15(6):281-92. PubMed ID: 8609807
[TBL] [Abstract][Full Text] [Related]
2. Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis.
Weber P; Brenner J; Stechemesser E; Klein R; Weckenmann U; Klöppel G; Kirchhof M; Fintelmann V; Berg PA
Hepatology; 1986; 6(4):553-9. PubMed ID: 3089894
[TBL] [Abstract][Full Text] [Related]
3. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance.
Berg PA; Klein R
Dig Dis; 1992; 10(2):85-101. PubMed ID: 1530697
[TBL] [Abstract][Full Text] [Related]
4. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation.
Klein R; Huizenga JR; Gips CH; Berg PA
J Hepatol; 1994 Feb; 20(2):181-9. PubMed ID: 8006398
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9.
Berg PA; Klein R
Klin Wochenschr; 1986 Oct; 64(19):897-909. PubMed ID: 3537495
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.
Klein R; Berg PA
Clin Exp Immunol; 1988 Oct; 74(1):68-74. PubMed ID: 2464450
[TBL] [Abstract][Full Text] [Related]
7. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation.
Haagsma EB; Manns M; Klein R; Grond J; Huizenga JR; Slooff MJ; Meyer zum Büschenfelde KH; Berg PA; Gips CH
Hepatology; 1987; 7(1):129-33. PubMed ID: 3542774
[TBL] [Abstract][Full Text] [Related]
8. [Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid].
Wirth HP; Zala G; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):750-4. PubMed ID: 7740290
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of antimitochondrial antibody profiles A-D in primary biliary cirrhosis].
Klein R; Berg PA
Dtsch Med Wochenschr; 1988 Oct; 113(40):1549-53. PubMed ID: 3168779
[TBL] [Abstract][Full Text] [Related]
10. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
11. Antimitochondrial and antinuclear antibodies in primary biliary cirrhosis: an update in relation to their biochemical characterization and clinical significance.
Brenard R; Geubel AP
Acta Clin Belg; 1991; 46(5):305-12. PubMed ID: 1721757
[TBL] [Abstract][Full Text] [Related]
12. Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years.
Klein R; Klöppel G; Garbe W; Fintelmann V; Berg PA
J Hepatol; 1991 Jan; 12(1):21-7. PubMed ID: 2007772
[TBL] [Abstract][Full Text] [Related]
13. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space.
Klein R; Berg PA
Clin Exp Immunol; 1991 Jun; 84(3):445-8. PubMed ID: 2044223
[TBL] [Abstract][Full Text] [Related]
14. Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis.
Feuchtinger M; Christ S; Preuss B; Dengjel J; Duman S; Stevanovic S; Klein R
Gut; 2009 Jul; 58(7):983-9. PubMed ID: 19336422
[TBL] [Abstract][Full Text] [Related]
15. The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis.
Klein R; Klöppel G; Fischer R; Fintelmann V; Müting D; Berg PA
J Hepatol; 1988 Jun; 6(3):299-306. PubMed ID: 3392380
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.
Fusconi M; Ghadiminejad I; Bianchi FB; Baum H; Bottazzo GF; Pisi E
Gut; 1988 Apr; 29(4):440-7. PubMed ID: 2453397
[TBL] [Abstract][Full Text] [Related]
17. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years.
Klein R; Pointner H; Zilly W; Glässner-Bittner B; Breuer N; Garbe W; Fintelmann V; Kalk JF; Müting D; Fischer R; Tittor W; Pausch J; Maier KP; Berg PA
Liver; 1997 Jun; 17(3):119-28. PubMed ID: 9249725
[TBL] [Abstract][Full Text] [Related]
18. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?
Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME
Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864
[TBL] [Abstract][Full Text] [Related]
19. Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies.
Garrido Palma G; Sánchez Cuenca JM; Olaso V; Pina R; Urquijo JJ; López Viedma B; Bustamante M; Berenguer M; Berenguer J
Rev Esp Enferm Dig; 1999 Mar; 91(3):168-81. PubMed ID: 10231308
[TBL] [Abstract][Full Text] [Related]
20. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?
Gisbert JP; Jones EA; Pajares JM; Moreno-Otero R
Aliment Pharmacol Ther; 2003 Jan; 17(1):17-27. PubMed ID: 12492729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
